NSE filing, NSE: PERSISTENT. Summary written from the filing by ALFA Finder's alert engine.
Persistent Systems Ltd: key numbers
- Share price
- ₹5,848.00
- Market cap
- ₹96,980 Cr
- Revenue (annual)
- ₹14,748 Cr
- Net profit (annual)
- ₹1,865 Cr
- P/E (TTM)
- 53.8×Sector 23.0×
- Promoter holding
- 30.29%+0.00% QoQ
- FII holding
- 20.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Persistent Systems Ltd
All →Persistent Systems Investor Presentation: Key Takeaways
Q2 FY27: USD revenue $487.6M, +20% YoY (+30.3% INR). Operating PAT Rs4,951.5M, +5% YoY; reported PAT Rs3,515.1M, -25.4% on Nagarro costs. Nagarro acquisition pending.
Persistent Systems Credit Rating
Persistent Systems received credit ratings from ICRA for its proposed Commercial Paper and Non-Convertible Debentures totaling ₹8,000 Crore.
- Value
- ₹8,000 Cr
Persistent Systems Fund Raise of ₹4,265 Cr
Persistent Systems' board approved a Qualified Institutional Placement (QIP) of equity shares, aiming to raise up to ₹4,264.61 Crore.
- Value
- ₹4,265 Cr
Persistent Systems Credit Rating
Persistent Systems received a 'CRISIL AA+; Rating Watch with Developing Implications' rating for its proposed Rs. 7,000 Crore Non-Convertible Debentures from CRISIL Ratings.
- Value
- ₹7,000 Cr
Persistent Systems Preferential Issue
Persistent Systems Ltd has clarified the floor price for its equity issue, set at ₹5,761.00 per share.
Persistent Systems Capital Structure Change
Persistent Systems opened its QIP issue with a floor price of Rs. 5,550 per share. The issue aims to raise up to Rs. 4,264.61 Crore.
- Value
- ₹4,265 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.